Medexus Pharmaceuticals Inc. endeavors to share all the information that our investors require in order to make informed investment decisions. For questions regarding our business operations, partnerships, our product pipeline/portfolio, or for general inquiries, please reach out us using the form provided.
Medexus Pharmaceuticals, Inc.
35 Nixon Road, Unit 1
Bolton, ON L7E 1K1
Canada
Ken d’Entremont
Chief Executive Officer and Director
ken.dentremont@medexus.com
905-676-0800
Marcel Konrad
Chief Financial Officer
marcel.konrad@medexus.com
312-548-3139
Ken d’Entremont
Business Development and Strategy
ken.dentremont@medexus.com
905-676-0800
Victoria Rutherford
Adelaide Capital
Tel: 480-625-5772
E-mail: victoria@adcap.ca
Direct Financial Strategies and Communication Inc.
Frank Candido
frank.candido@medexus.com
514-969-5530
USA: For adverse events, medical inquiries, and product-related concerns, please call 1-855-336-3322.
Canada: For adverse events, medical inquiries, and product-related concerns, please call 1-877-633-3987 or by written at MedexusPV@innomar-strategies.com.